000 | 01457 a2200385 4500 | ||
---|---|---|---|
005 | 20250513171600.0 | ||
264 | 0 | _c19990420 | |
008 | 199904s 0 0 eng d | ||
022 | _a0026-895X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlbani-Torregrossa, S | |
245 | 0 | 0 |
_aAntagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine versus 3, 5-dihydroxyphenylglycine. _h[electronic resource] |
260 |
_bMolecular pharmacology _cApr 1999 |
||
300 |
_a699-707 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCyclopropanes _xpharmacology |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aGlycine _xanalogs & derivatives |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aPhospholipase D _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors |
650 | 0 | 4 |
_aResorcinols _xpharmacology |
650 | 0 | 4 | _aStereoisomerism |
700 | 1 | _aAttucci, S | |
700 | 1 | _aMarinozzi, M | |
700 | 1 | _aPellicciari, R | |
700 | 1 | _aMoroni, F | |
700 | 1 | _aPellegrini-Giampietro, D E | |
773 | 0 |
_tMolecular pharmacology _gvol. 55 _gno. 4 _gp. 699-707 |
|
999 |
_c10060655 _d10060655 |